financial estimates
Ortho Clinical Diagnostics Q1 Revenues Rise 24 Percent on Core Revenue Strength
The firm's Q1 core revenues, which exclude contract manufacturing and other licensing revenues, rose 23 percent year over year to $499.3 million.
Quidel Preliminary Q1 Revenues Double But Fall Far Short of Expectations
The firm also announced a partnership with McKesson to enable more widespread distribution of its over-the-counter SARS-CoV-2 antigen test.
HTG Molecular Preliminary Q1 Revenues Fall 56 Percent
For the three months ended March 31, the firm said that preliminary revenues for Q1 are expected to be $1.4 million compared with $3.2 million a year ago.
360Dx Index Declines 2 Percent in March, Continuing Downward Slope
Of the 31 companies in the index, 11 firms saw their stock prices increase, while 20 saw their share prices decline.
Exagen Q4 2020 Revenues Up 24 Percent, Full Year Revenues Grow 4 Percent
The company's fourth quarter revenues rose to $12.7 million, while full year revenues rose to $42 million.
Feb 11, 2021
LabCorp Q4 Revenues Rise 52 Percent
Feb 2, 2021
PerkinElmer Q4 Revenues Spike 68 Percent
Jan 13, 2021
OpGen Preliminary Q4 Revenue Climbs 63 Percent
Jan 11, 2021
Invitae 2020 Preliminary Revenues Rise 28 Percent
Jan 11, 2021
PerkinElmer Q4 Revenues Expected to Rise 66 Percent
Oct 13, 2020
Qiagen Preliminary Q3 Revenues Up 26 Percent
Oct 7, 2020
CareDx Preliminary Q3 Revenues Up 57 Percent
Jul 28, 2020